8,930€
-0,48%
Echtzeit-Aktienkurs Astellas Pharma Inc.
Bid:
Ask:
Echtzeit-Chart der Astellas Pharma Inc. Aktie
Börsenkurse Astellas Pharma Inc.
| Börse Stuttgart | - | - | - | - | 8,990€ | 0,92% |
| Tradegate | - | - | - | - | 8,899€ | -0,20% |
| Lang & Schwarz | - | - | - | - | 8,930€ | -0,48% |
| Echtzeit Euro | - | - | - | - | 8,990€ | 1,01% |
| Börse Frankfurt | - | - | - | - | 8,830€ | 3,15% |
| gettex | - | - | - | - | 8,982€ | 0,41% |
Profil der Astellas Pharma Inc. Aktie
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.